Cardiovascular Innovations and Applications
@cvia-journal
Platinum open-access journal in cardiovascular medicine. Impact Factor 1.4 | CiteScore 1.2 | SJR Q3. Publishing innovative research with rapid peer review & no author fees.
TAVR shows similar outcomes to SAVR in low‑risk patients over 5–10 yrs, with faster recovery. But risks of valve thrombosis, paravalvular regurgitation, and pacemaker implantation remain. Review highlights why reintervention planning is key. Read more - tinyurl.com/253dyozb
This systematic review examines how aging contributes to cardiovascular pathology via metabolic dysregulation, mitochondrial dysfunction, chronic inflammation, cellular senescence, immune disorders & epigenetic changes. #CVIA #Cardiology #CardiovascularAging cvia-journal.org/cardiovascul...
ACS remains a major cause of mortality; this review explores cytokines and novel #biomarkers, highlighting their role in advancing risk models and AI driven strategies for more accurate, personalized cardiovascular care. #cardio #health Check this Article - tinyurl.com/24dmcjen
Global HDP rates are falling - but low SDI regions remain disproportionately affected. Targeted interventions and socioeconomic strategies are needed to reduce this persistent burden. #CVIA #MaternalHealth #HealthEquity #GlobalHealth Check this article👇 tinyurl.com/2y7rpdv3
Amino acid metabolism is emerging as a key driver of #DiabeticCardiomyopathy & #Atherosclerosis. This study shows how it influences #OxidativeStress, #Inflammation & #Fibrosis - pointing to new metabolic targets. #CVIA #Cardiology #DiabetesResearch Check this article - tinyurl.com/2bxqy4t4
Evidence shows ICCVD incidence resurging with early onset cases rising among women. Despite projected DALY declines by 2050, fatal burden persists, requiring urgent strategies for #RiskFactorManagement. #CVIA #CardiovascularHealth Check link in the comment 👇
This editorial provides new insights into #Arrhythmia #SleepApnea interactions, revealing unexpected trial results, driving a call for personalized approaches and future innovations in patient care. Read more: tinyurl.com/26sg48xd
This review examines the #molecular and #clinical dimensions of #Osteoprotegerin in #CardiovascularDisease, underscoring its regulatory and #Biomarker potential within the OPG/#RANKL/TRAIL axis for #PrecisionMedicine. Read more: tinyurl.com/2a44ushe
This review maps the structural and functional landscape of #Panx1, detailing its physiological roles, #PostTranslationalModifications, and activation mechanisms, with implications for #CardiovascularHealth and disease. Read More: tinyurl.com/25w78tqw
This practical overview helps frontline clinicians detect advanced #HeartFailure signs and make timely referrals to specialists, improving care pathways and #PatientOutcomes. #OpenAccess: cvia-journal.org/advanced-hea...
#HeartFailure remains a global challenge, and this editorial highlights that the promise of #GuidelineDirectedMedicalTherapy (#GDMT) can only be realized through system‑wide reorientation toward rapid initiation, optimization, and sustained adherence. Check this article: tinyurl.com/28mrlffv
This study shows distinct socioeconomic, lifestyle, and #clinical factors linked to #CardiovascularDisease among #Cancer survivors; however, as findings are self‑reported and cross‑sectional, cautious interpretation is warranted. #OpenAccess: cvia-journal.org/cancer-survi...
Cardiovascular Innovations and Applications (CVIA) achieved a 2025 Journal Impact Factor™ of 2.6, advancing to Q2 in Journal Citation Reports. Marking the 4th consecutive year of growth. Thanks to our authors, reviewers, Editorial Board & readers. #OpenAccess: cvia-journal.org/slug-cvia-im...
This review highlights that serum #UricAcid (UA) levels correlate positively with #AtrialFibrillation (AF) burden in a dose dependent manner, underscoring UA as an accessible #Biomarker and #therapeutic target for AF. Read More: tinyurl.com/2xmbhnvb
#WorldBloodDonor Day! Highlighting the need for research into transfusion medicine to optimize outcomes in cardiovascular surgeries & emergency cardiac care, #CVIA publishes research into blood management that improve life-saving transfusion outcomes. Click: cvia-journal.org
This review synthesizes classification of #Magnetocardiography device, technological developments, and #clinical applications in #CVD diagnosis, highlighting market challenges, future prospects, and potential roles in #Cardiology. Read More: tinyurl.com/2dzbouml
This editorial highlights that chronic RVP can provoke #dyssynchrony and PICM, while #LBBAP offers near‑native activation with stable outcomes; however, its preventive role in PICM and broader adoption still require long‑term validation. #OpenAccess:https://cvia-journal.org/chronic-rvp-lbbap-picm/
This review highlights the opportunities and limitations of #LongitudinalMethods in #CardiovascularResearch, provides intuitive descriptions, and emphasizes practical guidance for method selection, validation, and transparent reporting. #OpenAccess: cvia-journal.org/cardiovascul...
This study describes a novel Second Valve Drag & Reposition (SVDR) technique that offers enhanced radial support for migrated valve #stents by reducing #Aortic #WallStress; though caution is warranted in patients at high risk of #CoronaryObstruction. Learn more: tinyurl.com/24r9hucg
This study evidences that sustained weight gain increases #AtrialFibrillation (AF) risk, whereas sustained weight loss reduces it, underscoring the importance of consistent lifestyle strategies for AF prevention and improved #Cardiovascular outcomes. #OpenAccess: cvia-journal.org/weight-manag...
This #CVIA study emphasizes early #PalliativeCare integration in advanced #HeartFailure, improving symptoms, enhancing quality of life and strengthening shared decision‑making, while reducing hospitalization & supporting caregivers. #OpenAccess:https://cvia-journal.org/palliative-care-heart-failure/
World #NoTobacco Day 2026: Understanding the #Cardiovascular risks of emerging nicotine products is essential for protecting #HeartHealth. #CVIA showcases advances in cardiovascular imaging driving better diagnosis & patient outcomes. Explore: cvia-journal.org
This study finds TGM2 elevated in #AcuteCoronarySyndrome & linked to #AcuteMyocardialInfarction, enhancing prognostic assessment for #CardiovascularEvents when combined with #Anatomical #RiskScores, underscoring its value in #RiskStratification. Read more: tinyurl.com/2xlmnoxp
#Preeclampsia research is vital for understanding long-term #CVD risks in women. #CVIA publishes clinical innovations in early prediction and preventative strategies to improve maternal heart health. #WorldPreeclampsiaDay Explore: cvia-journal.org
This study shows that #SerumUricAcid (UA) levels correlate dose dependently with #AtrialFibrillation (AF) burden, positioning UA as an accessible #Biomarker and potential #therapeutic target for AF assessment and management. #openaccess: tinyurl.com/2xmbhnvb
Control It, Live Longer! On #WorldHypertensionDay, #CVIA stresses the importance of precise monitoring. We publish peer-reviewed research on therapies & lifestyle interventions focusing on #Cardiovascular innovations that enhance hypertension outcomes. Visit: cvia-journal.org
This editorial emphasizes key advances in circulating #Biomarkers for #AbdominalAorticAneurysm, highlighting their potential to improve early detection and risk assessment in #VascularMedicine. Read More: tinyurl.com/24n7sh5v
This #CVIA study confirms that reducing #SedentaryBehavior improves stroke prognosis and provides essential theoretical support for developing targeted #RehabilitationStrategies and optimizing outcome measures in patients with #stroke. #OpenAccess cvia-journal.org/stroke-seden...
This #CVIA study reframes #Asprosin biology in #CardiovascularResearch by focusing on signaling pathways and tissue‑specific effects, underscoring the importance of methodological rigor in advancing future #PrecisionMedicine strategies. #OpenAccess www.scienceopen.com/hosted-docum...
This cohort study shows that #Rivaroxaban use in AMI patients with #AtrialFibrillation on #AntiplateletTherapy reduced #IschemicStroke risk, while mortality and bleeding outcomes remained unchanged. tinyurl.com/28v9slf3